Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:

Clipper Realty Inc. CLPR: This real estate companyhas seen the Zacks Consensus Estimate for its current year earnings increasing 43.6% over the last 60 days.

Clipper Realty Inc. Price and Consensus

Clipper Realty Inc. price-consensus-chart | Clipper Realty Inc. Quote

Harrow, Inc. HROW: This eye care pharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 164.3% over the last 60 days.

Harrow, Inc. Price and Consensus

Harrow, Inc. price-consensus-chart | Harrow, Inc. Quote

Amicus Therapeutics, Inc. FOLD: This biotechnology company has seen the Zacks Consensus Estimate for its current year earnings increasing 10% over the last 60 days.

Amicus Therapeutics, Inc. Price and Consensus

Amicus Therapeutics, Inc. price-consensus-chart | Amicus Therapeutics, Inc. Quote

GitLab Inc. GTLB: This software development company has seen the Zacks Consensus Estimate for its current year earnings increasing 27.8% over the last 60 days.

GitLab Inc. Price and Consensus

GitLab Inc. price-consensus-chart | GitLab Inc. Quote

Trip.com Group Limited TCOM: This travel services company has seen the Zacks Consensus Estimate for its current year earnings increasing 6.3% over the last 60 days.

Trip.com Group Limited Sponsored ADR Price and Consensus

Trip.com Group Limited Sponsored ADR price-consensus-chart | Trip.com Group Limited Sponsored ADR Quote

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.  

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Amicus Therapeutics, Inc. (FOLD) : Free Stock Analysis Report

Clipper Realty Inc. (CLPR) : Free Stock Analysis Report

Harrow, Inc. (HROW) : Free Stock Analysis Report

Trip.com Group Limited Sponsored ADR (TCOM) : Free Stock Analysis Report

GitLab Inc. (GTLB) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research